Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Abciximab Versus Aspirin for Prevention of Stroke Recurrence Before Endarterectomy in Symptomatic >50% Carotid Stenosis: A Pilot Study (ASTERICS)

NCT00126139 is registered in ClinicalTrials.gov with University of Zurich as lead sponsor.

NCT NCT00126139
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00126139 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Abciximab Versus Aspirin for Prevention of Stroke Recurrence Before Endarterectomy in Symptomatic >50% Carotid Stenosis: A Pilot Study (ASTERICS)
Lead sponsor
University of Zurich
Phase
Phase 3
Overall status
Terminated
Start date
April 30, 2004
Completion date
May 31, 2005
Enrollment
100
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

stenosis, stroke